VIDEO
Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’ Alzheimer’s trial drug called Rember.
WSJ’s Shirley Wang spoke with Dr. Wischik about his work on this new drug to treat the devastating disease.
Visit Our Pages On:
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
